Matcha for Hay Fever: Green Tea Powder May Reduce Sneezing

Could a daily cup of matcha tea offer relief from the frustrating symptoms of seasonal allergies? Emerging research suggests a potential link between the popular Japanese green tea and a reduction in sneezing, offering a novel approach to managing allergic rhinitis, commonly known as hay fever. While still early, the findings, stemming from a study conducted on mice, point to a fascinating mechanism – a possible “dial down” of the sneeze reflex itself, rather than simply suppressing the broader immune response.

Matcha’s Existing Profile: Beyond a Trendy Beverage

Matcha isn’t new to the health conversation. This vibrant green powder, made from finely ground tea leaves, has been gaining recognition for its rich concentration of biologically active compounds. Previous studies have linked matcha consumption to benefits ranging from improved heart and brain function to reduced inflammation. These compounds include potent antioxidants and amino acids, contributing to its growing reputation as a health-promoting beverage.

The Research: Targeting the Sneeze Reflex in Mice

Professor Osamu Kaminuma, from the Research Institute for Radiation Biology and Medicine at Hiroshima University in Japan, initiated this research with a specific question: could matcha alleviate the symptoms of allergic rhinitis? “Human studies suggest green tea may relieve allergic rhinitis, but how it works is unclear,” Kaminuma explained. His team’s work, published in npj Science of Food on March 5, 2026, involved a carefully designed experiment using mice engineered to exhibit hay fever-like symptoms.

The mice received matcha tea two to three times a week for over five weeks, with an additional dose administered 30 minutes before exposure to an allergen. The results were striking: the mice experienced significantly fewer sneezes than expected. However, the most intriguing aspect of the study wasn’t just the reduction in sneezing, but how matcha appeared to achieve this effect.

Beyond IgE and Mast Cells: A Novel Mechanism

Typically, allergic reactions are driven by a cascade of immune responses involving immunoglobulin E (IgE) antibodies, mast cells and T cells. IgE antibodies bind to mast cells, triggering the release of histamine and other inflammatory chemicals. Mast cells are key players in the initial stages of an allergic reaction, while T cells contribute to longer-term immune processes, including IgE production. Surprisingly, the study found that matcha didn’t significantly impact these traditional allergy pathways.

Instead, the research team discovered that matcha appeared to directly suppress the neural mechanisms underlying the sneezing reflex. They focused on the activity of a gene called c-Fos, an indicator of neurological activity in response to stimuli. In mice experiencing allergic reactions, c-Fos expression increased in the ventral spinal trigeminal nucleus caudalis – a region of the brain involved in sneezing. Matcha treatment, however, significantly reduced c-Fos expression, bringing levels almost back to normal. “Oral matcha reduced sneezing without clearly changing major immune markers. Instead, it strongly suppressed brainstem neuronal activation linked to the sneezing reflex,” Kaminuma clarified.

What Does This Signify for Allergy Sufferers?

The findings suggest that matcha may offer a unique approach to managing allergic rhinitis symptoms. Rather than broadly suppressing the immune system, it seems to target the specific neurological pathway responsible for triggering sneezes. This is a potentially significant distinction, as broad immunosuppression can have unwanted side effects. However, it’s crucial to remember that this research was conducted on mice, and the results may not directly translate to humans.

The study, detailed in npj Science of Food, involved continuous intragastric administration of hot water-extracted matcha (250 mg/kg) to the mice. The researchers also noted that ethanol-extracted matcha slightly enhanced T cell proliferation, but this effect didn’t appear to be central to the observed reduction in sneezing. Importantly, the study did not find any significant impact on intestinal microbiota diversity, suggesting the effect isn’t mediated through changes in gut bacteria.

The Next Steps: From Mice to Human Trials

Professor Kaminuma and his team are now focused on determining whether these effects are replicated in human studies. “The goal is an evidence-backed, food-based option that complements standard care for allergic rhinitis symptoms,” he stated. Further research will be needed to determine the optimal dosage of matcha for humans, as well as to assess its long-term safety and efficacy. It’s also important to investigate whether the effects are consistent across different populations and types of allergies.

For now, while the prospect of a simple, natural remedy for allergy symptoms is appealing, it’s essential to approach these findings with cautious optimism. Individuals experiencing allergic rhinitis should continue to follow the advice of their healthcare providers and adhere to established treatment plans. This research offers a promising avenue for future investigation, but more work is needed before matcha can be recommended as a standard treatment for allergies.

Further Research and Monitoring: The research team plans to continue investigating the specific neural pathways involved in matcha’s effects, as well as exploring the potential for developing targeted therapies based on these findings. Ongoing surveillance of clinical trial results will be crucial in determining the true potential of matcha as an allergy treatment.